SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

MPS Pharmaa - Quaterly Results

12 Aug 2025 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2025, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2025 is Rs. -2.20 millions as compared to Net Loss of Rs. -2.23 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -1.92% as compared to -1.93% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.04 0.00 0.00 0.04 0.00 0.48 0.94 -48.94
PBIDT -1.92 -1.93 -0.52 -1.92 -1.93 -0.52 -7.17 -7.05 1.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PBDT -1.92 -1.93 -0.52 -1.92 -1.93 -0.52 -7.18 -7.06 1.70
Depreciation 0.37 0.37 0.00 0.37 0.37 0.00 1.47 1.47 0.00
PBT -2.29 -2.30 -0.43 -2.29 -2.30 -0.43 -8.65 -8.53 1.41
TAX -0.09 -0.07 28.57 -0.09 -0.07 28.57 0.34 -0.22 -254.55
Deferred Tax -0.09 -0.07 28.57 -0.09 -0.07 28.57 0.00 -0.22 -100.00
PAT -2.20 -2.23 -1.35 -2.20 -2.23 -1.35 -8.99 -8.31 8.18
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

MPS Pharmaa Share Price

1.73 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.25
Dr. Reddys Lab 1235.85
Cipla 1236.25
Zydus Lifesciences 941.20
Lupin 2336.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×